Edwards Life Sciences Corp. (EW): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Edwards Life ( EW) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.2%. By the end of trading, Edwards Life rose $1.24 (1.8%) to $71.70 on average volume. Throughout the day, 1,256,510 shares of Edwards Life exchanged hands as compared to its average daily volume of 1,086,600 shares. The stock ranged in a price between $70.60-$72.61 after having opened the day at $70.60 as compared to the previous trading day's close of $70.46. Other companies within the Health Services industry that increased today were: Sunshine Heart ( SSH), up 14.4%, Unilife Corporation ( UNIS), up 11.6%, CardioNet ( BEAT), up 8.6% and ImmunoCellular Therapeutics ( IMUC), up 8.4%.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Life has a market cap of $7.8 billion and is part of the health care sector. Shares are down 21.9% year to date as of the close of trading on Tuesday. Currently there are 9 analysts that rate Edwards Life a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front, Addus Homecare Corporation ( ADUS), down 5.5%, ERBA Diagnostics ( ERB), down 5.5%, Stereotaxis ( STXS), down 5.4% and SunLink Health Systems ( SSY), down 4.7% , were all laggards within the health services industry with DaVita HealthCare Partners ( DVA) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Edwards Lifesciences: Cramer's Top Takeaways

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Hold on Concert's Hair Loss Trials Pushes Shares Down 10%

Edwards Lifesciences Is Not Skipping A Beat

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock